Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants approval for Qbrexza cloth as treatment of primary axillary hyperhidrosis

July 2, 2018

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

July 2, 2018

ZYDG-2, a GPR40 agonist for potential treatment of type 2 diabetes

July 2, 2018

Phase Ib data on intravenous dexmedetomidine support BioXcel's development of sublingual BXCL-501

July 2, 2018

Thinning out fat cells

July 2, 2018

Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis

June 29, 2018

First-in-human results presented from VANCE study of ChAdOx1-MVA 5T4 vaccine

June 29, 2018

G1T38 demonstrates safety and early evidence of antitumor activity in breast cancer

June 29, 2018

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

June 29, 2018

Novartis to spin off Alcon eye care devices business

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...